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ABSTRACT: A methodology to build (E)-β-alkoxy- and (E)-β-
aryloxyacrylate moieties from acetate and formate esters
promoted by the TiCl4/Et3N system is presented. The reaction
is compatible with a broad range of structural skeletons and
elapses through an unusual condensation pathway. Taking into
account the obtained results, we propose a plausible mechanism
involving a bimetallic titanium intermediate for this type of transformation.
The β-alkoxyacrylate unit is a common structural motifpresent in biologically active natural and synthetic
products, such as indole alkaloids,1 strigolactones,2 and β-
methoxyacrylate fungicides (strobilurins, oudemansins, melithia-
zoles, haliangicins).3 This α,β-unsaturated moiety is a versatile
synthon that allows building several heterocyclic structures and,
recently, has served as an intermediate in natural products
synthesis, such as (±)-gracilioether E (ene reaction),4a
rocaglamide (metalation),4b (±)-hippolachnin A (ene reac-
tion),4c ABC ring fragment of gymnocin A (radical cycliza-
tion),4d C′D′E′F′ ring fragment of maitotoxin (radical
cyclization),4e (±)-civet (Prins reaction),4f and (+)-vigulariol
(radical cyclization).4g
Despite the synthetic applicability of β-alkoxyacrylates, they
aremainly prepared by conjugate addition of alcohols/phenols to
propiolate esters (Figure 1a).4b,d−g,5 Other less employed
alternatives (Figure 1b) consist of esterification of alcohols
with 3-alkoxyacryloyl chloride,6 Wittig reaction between
(phosphanylidene)acetates and alkyl formates,7 addition/elim-
ination of alcohols to β-iodo- or β-methoxyacrylates,4c,5g,h,8 and
Reformatsky reaction with bromoacetates.9 The existence of a
single methodology for obtaining this synthon has led us to
search for a new possible route via a retrosynthetic analysis with
two disconnections (Scheme 1): the first based on O-alkylation
of a formylacetate derivative followed by a Claisen condensation.
Herein, we describe an efficient method to introduce a β-alkoxy-
or β-aryloxyacrylate unit in different acetate esters using alkyl/
aryl formates combined with a TiCl4/Et3N system through an
unusual condensation pathway (Figure 1c).
Claisen and Dieckmann condensations mediated by titanium
enolates generated by TiCl4 and a tertiary amine
10 have gained
great importance over traditional methods (enolates generated
by strong bases, such as LDA and LHMDS) due to the following
advantages: high reaction velocities, good yields, a ready available
low-toxic metal (TiCl4), use of practical amines (Et3N or Bu3N),
and toleration of basic labile functionalities. The α-formylation of
diverse esters employing the TiCl4/Et3N system combined with
methyl formate was reported by Tanabe et al.,10c but to our
knowledge, acetate esters have not been assayed.
Phenyl acetate (1a) was chosen as a model substrate and was
subjected to a preliminary condensation conditions using methyl
formate (2a) (1.2 equiv), TiCl4 (1.3 equiv), and Et3N (3.0 equiv)
(entry 1, Table 1). The reaction was followed by TLC, and after
an hour, a slightly more polar product had formed. The 1H NMR
analysis of the reaction crude showed unreacted 1a, the desired
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Figure 1. (a) Main route for synthesizing β-alkoxyacrylates by conjugate
addition; (b) reported alternative routes; (c) novel building of β-alkoxy-
and β-aryloxyacrylate units from acetate and formate esters promoted by
TiCl4/Et3N.
Scheme 1. Retrosynthetic Analysis for β-Alkoxyacrylates
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formylacetate 4 as minor product, along with the enol form 5
and, unexpectedly, phenyl (E)-β-methoxyacrylate (3aa). The last
compound could be derived from a formal dehydration during a
Claisen condensation. Three related reactions that involve 3-
substituted pent-2-enedioates11 or thioesters12 as starting
materials have been described. The increase of metal source
produced a similar yield of 3aa (entry 2, Table 1), but an increase
of the hydrolysis of 1a was observed. A greater proportion of the
formyl source not only improved the yield but also prevented the
hydrolysis of the acetate ester (entry 3, Table 1). Factors such as
concentration (entry 4, Table 1) or reaction time (entry 5, Table
1) did not significantly affect neither the product ratio nor the
yield of 3aa. Better results were obtained by increasing the
amount of TiCl4 (entry 6, Table 1). Instead, when the amine load
was increased, the yield was lower (entry 7, Table 1). As
concentration could affect the solubility of other acetate esters in
further assays, an experiment under more dilute conditions was
tested (entry 8, Table 1). The dilution did not affect the yield of
3aa but showed unreacted starting material. The above problem
was solved with a slight increase of both TiCl4 and Et3N (entry 9,
Table 1). Finally, the use of one-half of the volume of solvents in
the workup produced the same result (entry 10, Table 1).
Once the optimal conditions for the synthesis of phenyl (E)-β-
methoxyacrylate (3aa) were established (Table 1), the scope of
the condensation was studied using formate esters 2b−2i
(Scheme 2). Ethyl (2b), n-heptyl (2c), cyclohexyl (2d), t-butyl
(2e), and benzyl (2f) substituents in the formyl source produced
the β-alkoxyacrylates 3ab−3ai with high yields, and unlike the
reaction crude from the 2a assay, the formylacetate derivative
with its enol form appeared as traces. The decrease of yield of 3ag
could be explained by the decomposition experienced by geranyl
derivatives. Aromatic formates 2h and 2i led to low yields, and 1H
NMR spectra of the reaction crudes showed a minor ratio of the
desired β-acrylate with respect to the formylacetate with the enol
form, 64:16:20 and 61:31:8, respectively.
Analysis of the scope was continued by choosing different
acetate esters with a wide structural diversity and, in some cases,
derived from natural products for their potential biological
implications. Non-heterocyclic acetates 1b−1pwere treated with
formate 2b as the formyl source (Scheme 3) due to its efficiency
and ease of removal under reduced pressure. Linear saturated
aliphatic acetates 1b,1c produced acrylate derivatives with high
yield, and even the reaction was effective with hindered starting
materials such as t-butyl acetate (1f), (−)-menthyl acetate (1d),
or (1R)-endo-(+)-fenchyl acetate (1e). Acetates in both allylic
(1g, 1h, and 1m) and benzylic (1k,1l) positions were also
compatible under the same reaction conditions with moderated
yields. Complex esters such as cholesteryl acetate (1i) or
stigmasteryl acetate (1j) and aromatic compounds such as
naphth-2-yl acetate (1o) gave good yields, although with eugenyl
acetate (1n), the yield decreased. The presence of more than one
ester group, as is the case of 1,4-tyrosyl acetate (1p), does not
affect the good yield of the corresponding bisacrylate 3pb.
Heterocyclic acetates 1q−1u (Scheme 4) constituted a second
set of tested substrates. Furan and thiophene rings, 1q and 1r,
were compatible with the reaction conditions and produced 3qb
and 3rb in moderated yields.
N-Acetoxyphthalimide (1s), 7-acetoxycoumarin (1t), and 4-
acetoxycoumarin (1u) were found to be labile acetates because,
in addition to the desired products, hydroxyl compounds derived
from the hydrolysis were observed in the crude reaction mixture.
The low yield obtained from acetate 1u can be explained by
considering its enol−acetate nature.
Finally, the study of the reaction scope was expanded to esters
other than acetates, such as γ-butyrolactone (1v), ethyl
propionate (1w), and methyl phenylacetate (1y) (Figure 2).
The aim was to study the behavior of esters that have been
Table 1. Optimization of Reaction Conditionsa
entry 2a (equiv) TiCl4 (equiv) Et3N (equiv) CH2Cl2 (mL) ratio
b 1a/3aa/4/5/6 yield of 3aa (%)c
1 1.2 1.3 3.0 3.0 50:39:2:1:8 37
2 1.2 2.6 3.0 3.0 0:60:3:1:36 35
3 3.3 1.3 3.0 3.0 45:49:3:2:1 46
4 3.3 1.3 3.0 1.5 41:52:3:3:1 49
5d 3.3 1.3 3.0 1.5 34:57:4:4:1 54
6 3.3 2.3 3.0 1.5 0:88:6:5:1 80
7 3.3 2.3 5.3 1.5 13:77:4:2:4 69
8 3.3 2.3 3.0 3.0 3:89:4:3:1 80
9 3.3 2.6 3.4 3.0 0:88:6:5:1 81
10e 3.3 2.6 3.4 3.0 0:88:6:5:1 79
aTiCl4 was added to a −20 °C solution of 1a (1.0 mmol), 2a, and Et3N under inert atmosphere. The mixture was stirred for 1 h at the same
temperature. bThe ratio was established from 1H NMR (400 MHz) analysis of reaction crude. cIsolated yield. dReaction stirred for 2 h at −20 °C.
eWorkup using half of the volume of the solvents.
Scheme 2. Scope of Formate Estersa,b
aAll reactions were carried out using 1a (1.0 mmol), formate esters
2a−2i (3.3 mmol), Et3N (3.4 mmol), TiCl4 (2.6 mmol), CH2Cl2 (3
mL), −20 °C, 1 h. bIsolated yield.
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employed in α-formylations using methyl or ethyl formate
combined with TiCl4 and Et3N.
10c,h Surprisingly, lactone 1v
exclusively produced the expected β-ethoxyacrylate 3vb, while
the other esters gave a 1:1 mixture of the α-formyl derivative and
(E)-β-ethoxyacrylate. These results are different than those
reported for Claisen condensations using TiCl4/Et3N, in which
the only product described was the 1,3-dicarbonyl derivative.
This behavior can be explained by differences in the reaction
conditions (larger reaction times, room temperature, and higher
acidity of the reaction media derived from TiCl4 hydrolysis in the
aqueous workup).
A plausible mechanism for this condensation is outlined in
Scheme 5. The need for a minimum of 2 equiv of TiCl4 involves
the formulation of a bimetallic intermediate, a hypothesis that has
been proposed by other authors.13
The mechanism begins by the formation of a 2:2 adduct
between TiCl4 with formate and acetate esters (intermediate I).
This intermediate exhibits two octahedral titanium cores with
two chlorine bridges and the alkoxide groups from the esters
away from the bimetallic plane, according to reported crystallo-
graphic structures for this type of metallic complex with ethyl
formate (2b) and ethyl acetate (1b).14 One equivalent of Et3N
would generate the bimetallic enolate II, which attacks the
carbonyl of ethyl formate to form the eight-membered
intermediate III. In a process favored by the high avidity of
titanium for oxygen, the removal of Hb by the amine and the
cleavage of the C−O bond give the bridged intermediate IV. The
anti-disposition of Hb with respect to the leaving group explains
its removal instead Ha. Finally, the coordinated (E)-β-
ethoxyacrylate ester is released upon workup. This mechanism
can explain the optimum yields when the amount of alkyl formate
was increased to 3.3 equiv because these conditions increase the
probability that acetate and formate are facing each other. The
reaction with γ-butyrolactone (1v) may be better explained by
intermediate III than the six-membered Zimmerman−Traxler
model because of lesser strain produced by the lactone. The
formation of formyl derivatives from 1w and 1y can also be
explained by this mechanism because only the (E)-enolate can
form intermediate III while the (Z)-isomer evolves through the
mechanism of the Claisen condensation to give the correspond-
ing 1,3-dicarbonyl derivatives. The absence of α-formylation with
γ-butyrolactone (1v) can be justified because it only produces the
(E)-enolate.
Scheme 3. Scope of Non-heterocyclic Acetate Estersa,b
aAll reactions were carried out using the acetate esters 1b−1o (1.0
mmol), 2b (3.3 mmol), Et3N (3.4 mmol), TiCl4 (2.6 mmol), CH2Cl2
(3 mL), −20 °C, 1 h. bIsolated yield. cReaction using 2b (9.9 mmol),
Et3N (10.2 mmol), and TiCl4 (5.2 mmol).
Scheme 4. Scope of Heterocyclic Acetatesa,b
aAll reactions were carried out using the acetate esters 1q−1u (1.0
mmol), 2b (3.3 mmol), Et3N (3.4 mmol), TiCl4 (2.6 mmol), CH2Cl2
(3 mL), −20 °C, 1 h. bIsolated yield.
Figure 2. Assays with esters other than acetates. All reactions were
carried out using γ-butyrolactone (1v), methyl propionate (1w), or
methyl phenylacetate (1y) (1.0 mmol); 2b (3.3 mmol), Et3N (3.4
mmol), TiCl4 (2.6 mmol), CH2Cl2 (3 mL), −20 °C, 1 h. Isolated yield.
Scheme 5. Plausible Mechanism for the Condensation
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In summary, we have studied an unusual condensation
reaction between formate and acetate esters promoted by the
TiCl4/Et3N system. This methodology has been optimized and
lets one introduce a β-alkoxy- or β-aryloxyacrylate moiety into
acetate esters of different nature. Based on the results, a
mechanism involving a bimetallic intermediate has been
proposed. This reaction increases the knowledge about the
titanium reactivity and could be a basis for future research. The
possible biological activity of these newly synthesized β-alkoxy-
and β-aryloxyacrylates is currently under study.
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B.; Herrmann, M.; Hecht, H.-J.; Sasse, F.; Forche, E.; Kunze, B.;
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